GCC In-Vitro Diagnostic Devices Market PDF: Global Size, Share, Trends, Analysis, Growth & Forecast to 2020-2025

1. GCC In-Vitro Diagnostic Devices Market Research Report and Forecast 2025 Report Edition: 2020 © 2020 IMARC All Rights Reserved Copyright © IMARC Service Pvt Ltd. All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description GCC In-Vitro Diagnostic Devices Market Overview: According to the latest report by IMARC Group, titled “GCC In-vitro Diagnostic Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the GCC in-vitro diagnostic devices market size reached US$ 969 Million in 2019. In-vitro diagnostic (IVD) devices refer to medical instruments that are used to perform tests using biological samples, such as blood, urine or tissue, taken from the human body. They are available in a wide variety, ranging from simple tests to sophisticated DNA analyzers, including calibrators, kits, software, reagents, control materials and other related instruments. IVD devices play a vital role in the GCC healthcare industry as they are crucial in the diagnosis of various medical conditions and infections, and monitoring drug therapies.

4. Report Description and Highlights Report Description GCC In-Vitro Diagnostic Devices Market Trends: The growing spread of the coronavirus disease (COVID-19) in the GCC countries has significantly boosted the market growth, as the World Health Organization (WHO) has listed two IVD tests for emergency use during the pandemic. These tests include the cobas SARS-CoV-2 Qualitative assay and Real-Time PCR Coronavirus (COVID-19). Additionally, the rising incidences of chronic diseases and the growing geriatric population are further driving the demand for IVD devices. As per the WHO, about 60% of deaths in the GCC countries are caused due to non-communicable diseases, such as diabetes, cancer and cardiovascular dysfunction. This has compelled governments of GCC countries to take initiatives to improve the healthcare services in the region. Some of these initiatives are aimed at investing in improved IVD devices, which are more accurate and efficient in executing diagnostic tests. This, along with the expanding insurance coverage under national health insurance programs, such as the Mandatory Health Insurance (MHI) schemes, to provide better and easy access to diagnostic devices, are boosting the sales of IVD devices across the region. Owing to these factors, the market value is projected to reach US$ 1,351 Million by 2025, expanding at a CAGR of 5.6% during 2020-2025. Request for a free sample report: https://www.imarcgroup.com/gcc-in-vitro-diagnostic-devices- market/requestsample

5. Report Description and Highlights Report Description GCC In-Vitro Diagnostic Devices Market Segmentation: Breakup By Type: • • • • • Hospital-based Centers Diagnostics Chains Standalone Centers Patient Self-testing Academic Institutes Based on the type, the market has been segmented into hospital-based centers, diagnostics chains, standalone centers, patient self-testing and academic institutes. Amongst these, in-vitro diagnostic devices are majorly used in hospital-based centers.

6. Report Description and Highlights Report Description Breakup By Application: • • • • • • • Infectious Diseases Diabetes Blood Test Nephrology Cardiology Oncology Autoimmune Diseases On the basis of the application, the market has been segregated into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology and autoimmune diseases. For more information, click here: https://www.imarcgroup.com/gcc-in-vitro-diagnostic-devices-market

7. Report Description and Highlights Report Description Breakup By Region: • • • • • United Arab Emirates Kuwait Qatar Oman Bahrain Region-wise, Saudi Arabia exhibits a clear dominance in the market. Other major regions include the United Arab Emirates, Kuwait, Qatar, Oman and Bahrain. Competitive Landscape: The competitive landscape of the market has been examined in the report with the detailed profiles of the key players operating in the industry.

8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. Report Description and Highlights Report Description © 2020 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com